Melatonin delays onset, reduces deaths in mouse model of Huntington's disease

October 11, 2011

Melatonin, best known for its role in sleep regulation, delayed the onset of symptoms and reduced mortality in a mouse model of Huntington's disease, say researchers at the University of Pittsburgh School of Medicine and Harvard Medical School. Their findings, published today in the Journal of Neuroscience, show for the first time that certain receptors for the hormone reside in the mitochondria, and that there are fewer of them both in affected mice and human brains.

Huntington's disease (HD) is an inherited, lethal disorder of involuntary movement, progressive loss of intellectual function and emotional problems, explained senior investigator Robert M. Friedlander, M.D., chair, Department of and UPMC Endowed Professor of neurosurgery and neurobiology. A , called huntingtin, kills neurons in the brain's and then the cortex.

"In earlier work, we screened more than 1,000 FDA-approved drugs to see which ones could block the release of a small protein called cytochrome c from the mitochondria to interrupt a key step in a chain reaction known as apoptosis, or ," he said. "Melatonin, which we know to be a , was one of the agents that could do this in the test tube, but we needed to determine if it would also be neuroprotective in a transgenic of HD."

For the study, the researchers injected HD mice daily with either melatonin or a placebo, evaluated them weekly for signs of the disease, and examined their brain tissue after death. They found that melatonin treatment delayed the onset of disease by 19 percent, slowed disease progression and prolonged life span by 18 percent.

The researchers determined also that type 1 melatonin (MT1) receptors are found on mitochondria, which supplies energy for the cell, and that they were depleted in both HD-affected human and mice samples. In lab experiments, administration of an agent that prevents melatonin from binding to the MT1 receptor encouraged cell death, while gene-engineering to increase the number of receptors led to greater neuroprotection, even when melatonin levels were normal.

"Extra melatonin might help fill all the available MT1 receptors, allowing the hormone to counter the programmed cell death cascade and thus protect neurons," Dr. Friedlander said. "This suggests that melatonin or similar agents that influence the MT1 receptor have potential as an HD treatment, which we've never had before."

Low levels of circulating melatonin have been seen in other neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. The research team is continuing to explore what might cause the loss of MT1 receptors and to assess other drugs that block cytochrome c and cell death.

"Perhaps the best approach will be to develop a cocktail of drugs that target different molecular pathways that are responsible for creating HD," Dr. Friedlander said. "We plan to see if combining different agents leads to a greater impact on disease progression and mortality."

Explore further: AMPK amplifies Huntington's disease

Related Stories

AMPK amplifies Huntington's disease

July 18, 2011
A new study describes how hyperactivation of AMP-activated protein kinase (AMPK) promotes neurodegeneration in Huntington's disease (HD). The article appears online on July 18, 2011, in The Journal of Cell Biology.

Recommended for you

'Residual echo' of ancient humans in scans may hold clues to mental disorders

July 26, 2017
Researchers at the National Institute of Mental Health (NIMH) have produced the first direct evidence that parts of our brains implicated in mental disorders may be shaped by a "residual echo" from our ancient past. The more ...

Laser used to reawaken lost memories in mice with Alzheimer's disease

July 26, 2017
(Medical Xpress)—A team of researchers at Columbia University has found that applying a laser to the part of a mouse brain used for memory storage caused the mice to recall memories lost due to a mouse version of Alzheimer's ...

Cellular roots of anxiety identified

July 26, 2017
From students stressing over exams to workers facing possible layoffs, worrying about the future is a normal and universal experience. But when people's anticipation of bad things to come starts interfering with daily life, ...

Cognitive cross-training enhances learning, study finds

July 25, 2017
Just as athletes cross-train to improve physical skills, those wanting to enhance cognitive skills can benefit from multiple ways of exercising the brain, according to a comprehensive new study from University of Illinois ...

Brain disease seen in most football players in large report

July 25, 2017
Research on 202 former football players found evidence of a brain disease linked to repeated head blows in nearly all of them, from athletes in the National Football League, college and even high school.

Zebrafish study reveals clues to healing spinal cord injuries

July 25, 2017
Fresh insights into how zebrafish repair their nerve connections could hold clues to new therapies for people with spinal cord injuries.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.